2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Nasopharyngeal Cancer
Nasopharyngeal cancer, a rare form of head and neck cancer, arises in the nasopharynx, the upper part of the throat behind the nose. Research in this field focuses on understanding the disease's molecular mechanisms, risk factors, and improving treatment outcomes. Key areas of investigation include exploring the role of Epstein-Barr virus (EBV) infection, genetic predisposition, and environmental factors such as diet and tobacco use in cancer development. Innovative therapies such as immunotherapy and targeted molecular treatments are being studied to enhance treatment efficacy and reduce side effects. Early detection methods, including advanced imaging techniques and biomarker identification, are also under scrutiny to improve prognosis and survival rates. Collaborative efforts between clinicians, researchers, and pharmaceutical companies drive progress in combating this challenging cancer type.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China